Avant

Medarex Announces 2008 Fourth Quarter and Year End Financial Results

... ======= ======= ======= ====== (1) In management's view, the operations of Celldex prior to its merger with avant Immunotherapeutics Inc.(effective March 7, 2008) are not necessarily indicative of or directly attributable to, Medarex's continuing operations. Celld...

Cogdell Spencer Announces Dorr as President of the Southeast Region

...as acquired by Cogdell Spencer in 2006. She has also held executive positions in asset management and healthcare division management with Edens & avant in Columbia, South Carolina. Ms. Dorr has more than twenty years of experience in real estate and expertise in asset management, finance, const...

Vaccine may double survival in patients with deadly brain tumors

...nical Oncology meeting in Chicago on June 2, 2008. The study was funded by the National Institutes of Health and Celldex Therapeutics, a subsidiary of avant Immunotherapeutics, which has licensed the rights to the vaccine and provided vaccine for use in the study. The vaccine targets a protein expressed...

AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to Pfizer

...Celldex Therapeutics (a wholly-owned subsidiary of avant Immunotherapeutics, Nasdaq: AVAN) announced today ...ling at 24 sites across the United States. About avant Immunotherapeutics, Inc. avant Immunotherapeutics and Celldex Therapeutics combin...

Medarex Announces 2008 First Quarter Financial Results

...(a subsidiary of Medarex) prior to its merger with avant Immunotherapeutics, Inc., and a non-cash charge of... 115,587 139,165 Investments in avant Immunotherapeutics 9,381 ...perations of Celldex prior to its merger with avant Immunotherapeutics, Inc. (effective March 7, 2008)...

The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan

...uxury vehicles that include the Audi A3 sport compact; the sporty A4 sedan, avant and Cabriolet models; the high performance S4 sedan, avant and Cabriolet models; the high-revving RS 4 sports sedan and Cabriolet (Nov...

And now it is vaccines for heart disease

...least a half-dozen studies under way to determine whether Chlamydia vaccine does indeed reduce heart and blood vessel disease in humans. avant Immunotherapeutics in Needham, Massachusetts has recently completed a preliminary trial of vaccine against cholesterol ester transfer protein (CETP), ...

Avant in Medical Technology

Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKline's Rotarix(R)

...e inventors at Cincinnati Children's; and in May 2005 acquired a portion of avant Immunotherapeutics' total royalties on Rotarix(R). "Rotavirus is a seriou...d initially developed by researchers now at Cincinnati Children's. In 1995, avant in-licensed the Rotarix(R) technology from Cincinnati Children's. GSK subse...

Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma

...utics announced a definitive merger agreement with avant Immunotherapeutics, Inc. (Nasdaq: AVAN ) in Octob...burg, New Jersey. On October 22, 2007, Celldex and avant Immunotherapeutics, Inc. announced that they had s... a vote of approval by the current stockholders of avant at a special meeting expected to take place in the...

Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme

...utics announced a definitive merger agreement with avant Immunotherapeutics, Inc. (Nasdaq: AVAN ) in Octob...burg, New Jersey. On October 22, 2007, Celldex and avant Immunotherapeutics, Inc. announced that they had s... a vote of approval by the current stockholders of avant at a special meeting expected to take place in the...

Avant's Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential

...h currently has over $200 million in annual sales. avant plans to initiate its own sponsored Phase 2 dose-r...n, Ph.D., President and Chief Executive Officer of avant Immunotherapeutics, Inc. "These results indicate t...tract No. NO AI 25459. About the Ty800 Vaccine avant has designed the Ty800 vaccine to offer rapid, ora...

Avant’s Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential

...red Phase 1/2 Study NEEDHAM, MA (May 18, 2007) - avant Immunotherapeutics, Inc. (Nasdaq: AVAN) announced ...mmune responses. Based on these excellent results, avant plans to further develop Ty800 to compete in the e...h currently has over $200 million in annual sales. avant plans to initiate its own sponsored Phase 2 dose-r...

Avant in Biological News

Building on pyramids of trash

...elephant dung and Damien Hirst's pickled tiger shark representing life and death to the unmade bed of Tracey Emin and the unspeakable bodily fluids of avant garde duo Gilbert & George. But all of these works will pale into insignificance if a plan to dispose of solid domestic and even toxic industrial wast...